Novelix Pharmaceuticals Limited (BOM:536565)

India · Delayed Price · Currency is INR

54.36

+1.69 (3.21%)

At close: Jun 3, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Wholesale - Drugs		295.09M	1.45M	2.13M	78.55M	45.08M
Wholesale - Drugs Growth		20232.03%	-31.92%	-97.29%	74.26%	-15.87%
Finance		159.58K	2.04M	2.73M	2.98M	3.34M
Finance Growth		-92.19%	-25.06%	-8.43%	-10.78%	-30.06%
Investment in Shares		-	664.78K	2.43M	2.54M	96.00K
Investment in Shares Growth		-	-72.64%	-4.29%	2544.79%	-78.81%
Trading in Shares		12.09M	41.15M	11.91M	7.56M	9.88M
Trading in Shares Growth		-70.62%	245.41%	57.55%	-23.49%	-4.46%
Food		-	-	-	-	37.46M
Food Growth		-	-	-	-	-4.69%
Total		307.34M	45.31M	19.20M	91.63M	95.86M
Total Growth		578.29%	135.96%	-79.04%	-4.41%	-11.62%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India		307.33M	45.31M	19.20M	89.13M	95.85M
India Growth		578.26%	135.96%	-78.45%	-7.01%	-11.60%
Total		307.33M	45.31M	19.20M	89.13M	95.85M
Total Growth		578.26%	135.96%	-78.45%	-7.01%	-11.60%

Source: S&P Global Market Intelligence.